Genmab A/S - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US3723032062

SecurityGMAB / Genmab A/S - Depositary Receipt (Common Stock)
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Citadel Advisors Llc ownership in GMAB / Genmab A/S - Depositary Receipt (Common Stock)

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 0 shares of Genmab A/S - Depositary Receipt (Common Stock) (US:GMAB) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 19,102 shares of Genmab A/S - Depositary Receipt (Common Stock). This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (GMAB) in the form of stock options. The firm currently holds call options representing 172,500 of underlying shares valued at $4,628,175 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GMAB / Genmab A/S - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GENMAB A SPONSORED ADS 372303206 0 -19,102 -100.00 0 -100.00
2026-02-17 2025-12-31 13F GENMAB A SPONSORED ADS 372303206 19,102 -32,371 -62.89 588 -62.74 0.0001
2025-11-14 2025-09-30 13F GENMAB A SPONSORED ADS 372303206 51,473 -3,517,711 -98.56 1,579 -97.86 0.0002
2025-08-14 2025-06-30 13F GENMAB A SPONSORED ADS 372303206 3,569,184 -857,470 -19.37 73,739 -14.92 0.0128
2025-05-15 2025-03-31 13F GENMAB A SPONSORED ADS 372303206 4,426,654 1,334,510 43.16 86,674 34.31 0.0164
2025-02-14 2024-12-31 13F GENMAB A SPONSORED ADS 372303206 3,092,144 1,792,288 137.88 64,533 103.64 0.0112
2024-11-14 2024-09-30 13F GENMAB A SPONSORED ADS 372303206 1,299,856 28,968 2.28 31,690 -0.77 0.0061
2024-08-14 2024-06-30 13F GENMAB A SPONSORED ADS 372303206 1,270,888 1,222,750 2,540.09 31,937 2,119.39 0.0065
2024-05-15 2024-03-31 13F GENMAB A SPONSORED ADS 372303206 48,138 -107,383 -69.05 1,440 -70.94 0.0003
2024-02-14 2023-12-31 13F GENMAB A SPONSORED ADS 372303206 155,521 -89,390 -36.50 4,952 -42.68 0.0010
2023-11-14 2023-09-30 13F GENMAB A SPONSORED ADS 372303206 244,911 -28,223 -10.33 8,638 -16.79 0.0019
2023-08-14 2023-06-30 13F GENMAB A SPONSORED ADS 372303206 273,134 -158,719 -36.75 10,382 -36.34 0.0021
2023-05-15 2023-03-31 13F GENMAB A SPONSORED ADS 372303206 431,853 30,699 7.65 16,307 -4.08 0.0036
2023-02-14 2022-12-31 13F GENMAB A SPONSORED ADS 372303206 401,154 85,560 27.11 17,001 67.65 0.0040
2022-11-14 2022-09-30 13F GENMAB A SPONSORED ADS 372303206 315,594 76,206 31.83 10,140 30.38 0.0023
2022-08-15 2022-06-30 13F GENMAB A SPONSORED ADS 372303206 239,388 115,930 93.90 7,777 74.14 0.0020
2022-05-16 2022-03-31 13F GENMAB A SPONSORED ADS 372303206 123,458 123,458 4,466 0.0009
2022-02-14 2021-12-31 13F GENMAB A Depository Receipt 372303206 0 -21,039 -100.00 0 -100.00
2021-11-15 2021-09-30 13F GENMAB A Depository Receipt 372303206 21,039 748 3.69 919 10.99 0.0002
2021-08-16 2021-06-30 13F GENMAB A SPONSORED ADS 372303206 20,291 20,291 828 0.0002
2021-05-21 2021-03-31 13F/A-1 GENMAB A SPONSORED ADS 372303206 0 -239,132 -100.00 0 -100.00
2021-02-16 2020-12-31 13F GENMAB A SPONSORED ADS 372303206 239,132 -43,578 -15.41 9,723 -6.06 0.0025
2020-11-16 2020-09-30 13F GENMAB A SPONSORED ADS 372303206 282,710 30,339 12.02 10,350 21.01 0.0029
2020-08-14 2020-06-30 13F GENMAB A Depository Receipt 372303206 252,371 227,512 915.21 8,553 1,522.96 0.0030
2020-05-15 2020-03-31 13F GENMAB A Depository Receipt 372303206 24,859 -417,900 -94.39 527 -94.67 0.0002
2020-02-14 2019-12-31 13F GENMAB A S Depository Receipt 372303206 442,759 -714,061 -61.73 9,887 -57.81 0.0043
2019-11-14 2019-09-30 13F GENMAB A S Depository Receipt 372303206 1,156,820 1,156,820 23,436 0.0111
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F GENMAB A SPONSORED ADS Call 172,500 541.26 4,628 458.94 n/a n/a n/a
2026-02-17 2025-12-31 13F GENMAB A SPONSORED ADS Call 26,900 -10.33 829 -10.00 n/a n/a n/a
2025-11-14 2025-09-30 13F GENMAB A SPONSORED ADS Call 30,000 63.93 920 143.39 n/a n/a n/a
2025-08-14 2025-06-30 13F GENMAB A SPONSORED ADS Call 18,300 -62.03 378 -59.92 n/a n/a n/a
2025-05-15 2025-03-31 13F GENMAB A SPONSORED ADS Call 48,200 207.01 944 188.38 n/a n/a n/a
2025-02-14 2024-12-31 13F GENMAB A SPONSORED ADS Call 15,700 53.92 328 31.85 n/a n/a n/a
2024-11-14 2024-09-30 13F GENMAB A SPONSORED ADS Call 10,200 50.00 249 45.88 n/a n/a n/a
2024-08-14 2024-06-30 13F GENMAB A SPONSORED ADS Call 6,800 -49.25 171 -57.50 n/a n/a n/a
2024-05-15 2024-03-31 13F GENMAB A SPONSORED ADS Call 13,400 14.53 401 7.53 n/a n/a n/a
2024-02-14 2023-12-31 13F GENMAB A SPONSORED ADS Call 11,700 10.38 373 -0.27 n/a n/a n/a
2023-11-14 2023-09-30 13F GENMAB A SPONSORED ADS Call 10,600 130.43 374 114.37 n/a n/a n/a
2023-08-14 2023-06-30 13F GENMAB A SPONSORED ADS Call 4,600 -86.59 175 -86.56 n/a n/a n/a
2023-05-15 2023-03-31 13F GENMAB A SPONSORED ADS Call 34,300 1,043.33 1,295 919.69 n/a n/a n/a
2023-02-14 2022-12-31 13F GENMAB A SPONSORED ADS Call 3,000 -98.27 127 -97.72 n/a n/a n/a
2022-11-14 2022-09-30 13F GENMAB A SPONSORED ADS Call 173,100 112.39 5,562 110.05 n/a n/a n/a
2022-08-15 2022-06-30 13F GENMAB A SPONSORED ADS Call 81,500 248.29 2,648 212.63 n/a n/a n/a
2022-05-16 2022-03-31 13F GENMAB A SPONSORED ADS Call 23,400 254.55 847 224.52 n/a n/a n/a
2022-02-14 2021-12-31 13F GENMAB A SPONSORED ADS Call 6,600 13.79 261 3.16 n/a n/a n/a
2021-11-15 2021-09-30 13F GENMAB A Depository Receipt Call 5,800 -46.30 253 -42.63 n/a n/a n/a
2021-08-16 2021-06-30 13F GENMAB A SPONSORED ADS Call 10,800 -83.10 441 -78.98 n/a n/a n/a
2021-05-21 2021-03-31 13F/A GENMAB A SPONSORED ADS Call 63,900 174.25 2,098 121.54 n/a n/a n/a
2021-05-17 2021-03-31 13F GENMAB A SPONSORED ADS Call 63,900 2,098 n/a n/a n/a
2021-02-16 2020-12-31 13F GENMAB A SPONSORED ADS Call 23,300 5.91 947 17.64 n/a n/a n/a
2020-11-16 2020-09-30 13F GENMAB A SPONSORED ADS Call 22,000 21.55 805 31.32 n/a n/a n/a
2020-08-14 2020-06-30 13F GENMAB A Depository Receipt Call 18,100 613 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F GENMAB A SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-17 2025-12-31 13F GENMAB A SPONSORED ADS Put 13,200 29.41 407 30.13 n/a n/a n/a
2025-11-14 2025-09-30 13F GENMAB A SPONSORED ADS Put 10,200 -61.94 313 -43.58 n/a n/a n/a
2025-08-14 2025-06-30 13F GENMAB A SPONSORED ADS Put 26,800 -29.47 554 -25.67 n/a n/a n/a
2025-05-15 2025-03-31 13F GENMAB A SPONSORED ADS Put 38,000 196.88 744 178.65 n/a n/a n/a
2025-02-14 2024-12-31 13F GENMAB A SPONSORED ADS Put 12,800 56.10 267 34.17 n/a n/a n/a
2024-11-14 2024-09-30 13F GENMAB A SPONSORED ADS Put 8,200 -36.92 200 -38.96 n/a n/a n/a
2024-08-14 2024-06-30 13F GENMAB A SPONSORED ADS Put 13,000 -5.80 327 -20.87 n/a n/a n/a
2024-05-15 2024-03-31 13F GENMAB A SPONSORED ADS Put 13,800 392.86 413 362.92 n/a n/a n/a
2024-02-14 2023-12-31 13F GENMAB A SPONSORED ADS Put 2,800 -3.45 89 -12.75 n/a n/a n/a
2023-11-14 2023-09-30 13F GENMAB A SPONSORED ADS Put 2,900 -14.71 102 -20.93 n/a n/a n/a
2023-08-14 2023-06-30 13F GENMAB A SPONSORED ADS Put 3,400 -59.04 129 -58.79 n/a n/a n/a
2023-05-15 2023-03-31 13F GENMAB A SPONSORED ADS Put 8,300 277.27 313 236.56 n/a n/a n/a
2023-02-14 2022-12-31 13F GENMAB A SPONSORED ADS Put 2,200 93 n/a n/a n/a
2022-02-14 2021-12-31 13F GENMAB A Depository Receipt Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F GENMAB A Depository Receipt Put 8,000 -85.13 350 -84.07 n/a n/a n/a
2021-08-16 2021-06-30 13F GENMAB A SPONSORED ADS Put 53,800 -60.76 2,197 -51.19 n/a n/a n/a
2021-05-21 2021-03-31 13F/A GENMAB A SPONSORED ADS Put 137,100 216.63 4,501 155.59 n/a n/a n/a
2021-05-17 2021-03-31 13F GENMAB A SPONSORED ADS Put 137,100 4,501 n/a n/a n/a
2021-02-16 2020-12-31 13F GENMAB A SPONSORED ADS Put 43,300 154.71 1,761 183.12 n/a n/a n/a
2020-11-16 2020-09-30 13F GENMAB A SPONSORED ADS Put 17,000 80.85 622 94.98 n/a n/a n/a
2020-08-14 2020-06-30 13F GENMAB A Depository Receipt Put 9,400 -22.31 319 24.61 n/a n/a n/a
2020-05-15 2020-03-31 13F GENMAB A Depository Receipt Put 12,100 256 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.